Healthtronics — Investor Presentation (September 2009)
29 slides from Healthtronics's investor presentation, Sep 10, 2009
Slide 1: HealthTronics
go \ 4 HealthTronics
Slide 2: Safe Harbor Statement
HealthtTroni Safe Harbor Statement Statements hy the Company's maragement mad in this presentation that are not strictly historical, including statements regarding plans, objectives and figure financial performance, are “forwartHooking” staternerts that are made pursuant: to the safe harbor provisio
Slide 3: Use of Non-GAAP Financial Measures
HealthTronics > Use of Non-GAAP Financial Measures This presentation incude: financial mecsures for net: income (oss), net income Qos) from continuing operations, and refated per share amounts thet exchuck: certain charges and therefore have not beat calculstea in accordance with US. generally accep
Slide 4: Corporate Overview
Corporate Overview Business Segments and Markets Recent Acquisitions and Growth Platform Selected Financial Information HealthTronics
Slide 5: Corporate Overview
HealthTronic: Corporate Overview pling Sala Manke GrowithPiatonmandurecent Acc: iieanvelaliimee tn eal [
Slide 6: Corporate Overview
HealthtTroni Corporate Overview * Leading Provider of Urology Services in the U.S. * Market leaders in Lithotripsy, BPH Laser and Cryosurgery * Goal to become urologic market leader in: — Anatomic Pathology —Radiation Therapy * Unique Business Relationship with Approximately One-Third of Urologists
Slide 7: Total Solution for Urology Marketplace
HealthTronicss | — Total Solution for Urology Marketplace TOTALCARE VapY Business Development Ops& Scheduling ‘Compliance & Regulatory Legal & Contracting Enabling Technologies Improve patient care Accounting Enhance practice economics Staffing & Certification isk Service & Mitigation Maintenance
Slide 8: HealthTronics Competitive Position
=~ Fa y =) a HealthTronics = . . ~ HealthTronics Competitive Position « Relationships with one-third of alll urologistsin the nation « Health Tronicsis a critical partner, co-investor, technology advisor and advocate + Health Tronicsis viewed as the most influential national pkyer in the Urology Ser
Slide 9: HealthTronics Value Proposition
<1 HealthTronicss | HealthTronics Value Proposition a Urologists ° Shared financial, operational and ° Accesso quality healthcare obsolescence risk > Ti of and jurnicey platform of products L : . * Urologists canfocus on patient ), Improves Practice | options Economics ~~] * Access to latest technol
Slide 10: Radiation Therapy
Radiation Therapy i oreal Shiork Wave: Lahouipsy. TBPH Laser + Cancer centers with IGRT deployed + Deployed in partnership with invested + Cryoablation a. Anatomic Pathology Devices, Maintenance and Consumables cHmomangorieie sharing network - Fulloffering of revenues i _ me oe noes = Equipment from
Slide 11: Business Segments and Markets
HealthTronic: IC onpore Business Segments and Markets Growth Rlationmrand etic lelinetmelell|in tevin
Slide 12: Lithotripsy and Prostate Therapies
HealthTronicss Lithotripsy and Prostate Therapies Provided on a mobile basis 90 Partnerships in over 40 States — 130+ Lithotripters — 55+ BPH Lasers — 25+ Cryo Units 70,000+ Lithotripsy and Prostate Procedures Performed Annually Treating at 500+ Hospitals and Surgery Centers Trusted Advisor to Urolo
Slide 13: Equity-Based Partnership Model
Equity-Based Partnership Model HealthTronics employs a successful lithotripsy partnership model ‘On average, 80%/20% physician/Health Tronics equity split in its partnerships Health Tronics shares in the initial capital investment Partnership profits distributed to equity hoklersbased on % ownership
Slide 14: Geographic Mix
<1 HealthTronicss Geographic Mix HealthTronics partnerships have a truly national presence with strong regional Presence in all the major markets throughout the United States . ° . ° Revenue by Region Partnership Distribution West 17% South ani Midwest Northeast 2%
Slide 15: Kidney Stone and BPH Market Data
Oo HealthTronicss Kidney Stone and BPH Market Data set Indication Market + Kidney Stones ° Extracorporeal Shock Wave Lithotripsy Services — Stones are hard masses that form arpwherein — Extracorporeal shocowave lithotripsy is a noninvasive the urinary tract and may cause pain, bleeding, method of br
Slide 16: Prostate Cancer Market Data
<1 HealthTronicss | Prostate Cancer Market Data - arget Indicatio ° Prostate Cancer + Cryabtation — Malignant growth of cellsin prostate gland ling GFomeer celts Eceldietibe > (Serie most Conminn career wi thelU.S.. — Over 15,000 procedures in the U.S.in 2008 : ADimlion Amencanines — Demand for foca
Slide 17: Radiation Therapy value and expertise
HealthTronics lue : <Goak:Svortan te Gres to eatent of frst pale * Urologists maintain focus on providing care to patients while minimizing {or eliminating} the out-of- pocket expense related to regulatory and consolidation concerns + Health Tronics professional tearn leads ravigation through comple
Slide 18: Anatomic Pathology
SS) HealthTronicss | Anatomic Pathology «The diagnosis of cancer and other diseases through the ecmination «Started providing services in january 2006. of tissues (biopsies) and cells (cytology) « Grew revenue by 49.6% in 2006. + Requires the services of a pathologst to make a diagnosis. «Historical
Slide 19: Devices, Maintenance and Consumables
HealthtTroni Devices, Maintenance and Consumables ¢ Conduit for New Technologies ° Products — Endocare Cryocare® CS for Cryoablation ¢ Fully integrated planning, placement and treatment system — RevolLix Laser for BPH ¢ Acontinuous wave laser that interacts ideally with prostate tissue allowing prec
Slide 20: Recent Acquisitions and Growth Platform
HealthTronic: IC onpore
Slide 21: Diversification of Revenue
Sa . HealthTronicss rn: ae £D Diversification of Revenue 2007 2008 2009 : 2007 — After Several Years in Deckne, ek: 2e18 Ocean Acremetion: Emmy mio GRE, Lithotipsy Business is Stabiized| “Aug. 2008 — UroPath Acquired, Increased ‘Commitment to Pathology July 2009. Endocare Acquired (2007 — ClaiPath L
Slide 22: Recent acquisitions: AMPI, UroPath, Ocean
+ Closed April 2008 for cash and stock totaling, «Closed in July 2008 for $7.5 million. approximately $15 million . i $ ed with “condo” « Leadingprovider of ntheus. Lstoricaly operate 25 2 urologist ovm coop + AMPListhe GP or managingmember in 25 phrysician partnerships servicing 46 states + Process
Slide 23: Endocare Acquisition
hTroni¢s f care Acquisitior Jee endocare + Deal dosed July 27th , Endocare now wholly owmed by * Significant synerges from redundant infrastructure (public: HealthiTronics. company costs, IT, HR, Accounting Marketing, etc}. «Total enterprise value of approaimately $20 million in + Consofdating manuf
Slide 24: HealthTronics Opportunities
-) HealthTronics 1 Opp Anatomic Pathology + Looking to acquire additional talent and < Hove bait infrastructure and acquired talent. with development and ops expertise + Leveraging Ocean acquisition as center of excellence + Continued bazzand trend of consolidation in urology marketplace Products Us
Slide 25: Selected Financial Information
HealthTronic: FOND
Slide 26: Selected Financial Information
Slide 27: Reconciliation of Adjusted EBITDA
Selected Financial Information Reconciliation of Adjusted EBITDA ‘Six Months Ended Jame 30, “Year Ended December 31, 2009 708 038 mor 7006 $ 7m $ 162 $ oe) S$ CHA) S$ GMO) ao aH a9 em asa) S88 ao gr B 9 LM6 O86 Spr 1363 LT 125 Tw 6H 192 3B ADA - - A 20800 2 Lo 199 2381 L110 12. $ 11000 $ 9982 $ 2A $
Slide 28: Selected Financial Information
Selected Financial Information 6f30/2009 12/31/2008 Sintowsnds _Sirthouent Total Current Assets $54,044 * $ 63,689 Total Debt $40,410 $ 46,387 “Delta is dueto $94 milion in distiitutions paid to noncontrofing interest in frst two weeks of January 2009. As of 6/30/2009 Actual Required Interest Covera
Slide 29: HealthTronics, Inc. End of Slides
<< = \ a ge” 4 HealthTronics [tL HealthTronics, Inc. End of Slides
HealthTronics — Investor Presentation (September 2009) on 6ix